Wealthspire Advisors, LLC Gilead Sciences, Inc. Transaction History

Wealthspire Advisors, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $334,533 - $480,274	5,368 New	5,368 $460,000
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $388,990 - $487,447	-6,716 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $16,933 - $19,220	-261 Reduced 3.74%	6,716 $488,000
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $472,273 - $509,530	6,977 New	6,977 $487,000
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $582,464 - $636,424	-9,177 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $145,560 - $166,083	2,426 Added 35.94%	9,177 $593,000
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $32,063 - $36,535	-566 Reduced 7.74%	6,751 $393,000
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $168,104 - $211,362	-2,707 Reduced 27.01%	7,317 $462,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $574,885 - $667,548	-7,947 Reduced 44.22%	10,024 $771,000
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $791,893 - $1.01 Million	12,644 Added 237.36%	17,971 $1.34 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $6,100 - $6,710	99 Added 1.89%	5,327 $346,000
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $326,802 - $360,732	5,228 New	5,228 $331,000
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $53,150 - $59,542	-850 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $51,459 - $67,150	850 New	850 $53,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthspire Advisors, LLC with notifications on news.